Peers for comparison



Key facts today


MDxHealth (MDXH) is due to report results Nov. 12 for the quarter ended Sept. 30. Analysts expect revenue of $28.75 million, up 4.8% year over year, and a loss of $0.09 per share. 1
Analyze the impactAnalyze the impact
Market capitalization
‪15.07 M‬ USDNano cap
−0.7330 USD
‪−33.52 M‬ USD
‪107.88 M‬ USD
‪64.98 M‬
Beta (1Y)
3.48
Next report date
Report period
EPS estimate
Revenue estimate
Employees (FY)
364
Change (1Y)
+52+16.67%
Revenue / Employee (1Y)
‪296.36 K‬ USD
Net income / Employee (1Y)
‪−92.09 K‬ USD

Company info


CEO
Michael K. McGarrity
Headquarters
Herstal
Founded
2003
IPO date
Nov 4, 2021
ISIN
BE0974461940
FIGI
BBG000VBX3M3
Identifiers
ISIN BE0974461940
CFI code
ESVUFN
MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, Europe and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


MDxHealth SA is scheduled to release its next earnings report on Nov 12, 2026.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
MDXH stock is 7.61% volatile and has beta coefficient of 3.48.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like MDXH are typically less volatile than smaller companies

Track every detail on MDxHealth SA stock chart and check out the list of the most volatile stocks — is MDxHealth SA there?
To understand the MDXH stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −7.73%
– 1 week — −9.22%
– 1 month — −74.68%

MDXH all-time low was 0.1393 USD (Nov 10, 2026), and its highest price is 13.1700 USD (Nov 4, 2021). Find more dynamics in the Stock Heatmap and on the MDxHealth SA stock chart.
MDxHealth SA market capitalization is ‪13.29 M‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from MDxHealth SA stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how MDxHealth SA stacks up against other companies
The safest way to buy MDxHealth SA stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade MDXH directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 11, 2026, the company has 364 employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Investing in MDxHealth SA depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study MDxHealth SA financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our MDXH technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell

Combine fundamental and technical analysis for better results.
MDxHealth SA stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, MDxHealth SA stocks trade under the symbol MDXH.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
MDXH earnings for the last quarter are −0.18 USD per share, whereas the estimation was −0.19 USD, resulting in a 6.91% surprise. The estimated earnings for the next quarter are −0.09 USD per share.

How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one

Follow other essential metrics in MDxHealth SA financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
MDxHealth SA revenue for the last quarter amounts to ‪27.21 M‬ USD despite the estimated figure of ‪26.14 M‬ USD. In the next quarter revenue is expected to reach ‪28.74 M‬ USD.

How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance

Follow other essential metrics in MDxHealth SA financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track MDxHealth SA financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
MDXH net income for the last quarter is ‪−11.53 M‬ USD, while the quarter before that showed ‪−8.87 M‬ USD of net income which accounts for −30.06% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in MDxHealth SA financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, MDxHealth SA does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
MDXH reached its all-time high of 13.1700 USD on Nov 4, 2021. Its all-time low was 0.1393 USD and was reached on Nov 10, 2026.

Explore the MDxHealth SA stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
MDxHealth SA EBITDA is ‪−11.87 M‬ USD, with an EBITDA margin of −5.74%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in MDxHealth SA statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 0.50 USD and 2.00 USD for MDXH, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance